Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine.
D000818:Animals; D002047:Buprenorphine / Q000494:pharmacology*; D010856:Columbidae; D004193:Discrimination Learning / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004091:Hydromorphone / Q000031:analogs & derivatives*; D051379:Mice; D009019:Morphinans / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology*; D009271:Naltrexone / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects*; D010111:Oxymorphone / Q000031:analogs & derivatives* / Q000494:pharmacology
D009019:Morphinans; D002047:Buprenorphine; D009271:Naltrexone; C034640:oxymorphazone; D009020:Morphine; D010111:Oxymorphone; D004091:Hydromorphone